Interdisciplinar teragnosis and radiosomics
INTRA
![Foto de Interdisciplinar teragnosis and radiosomics](/img/uploaded/725e11b0e3e8f2aa04eebc6fa7d3c9dd.jpg)
![Foto de University of Paris-Sorbonne](/img/noimage_org.png)
University of Paris-Sorbonne
París, FranciaPublicacións en colaboración con investigadores/as de University of Paris-Sorbonne (4)
2022
-
2022 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer, including patients with COVID-19
The Lancet Oncology, Vol. 23, Núm. 7, pp. e334-e347
-
Enoxaparin versus dalteparin or tinzaparin in patients with cancer and venous thromboembolism: The RIETECAT study
Research and Practice in Thrombosis and Haemostasis, Vol. 6, Núm. 4
-
Outcome of Cancer-Associated Venous Thromboembolism Is More Favorable among Patients with Hematologic Malignancies than in Those with Solid Tumors
Thrombosis and Haemostasis, Vol. 122, Núm. 9, pp. 1594-1602